News Orders & Deals Pronomz Ventures LLP Increases Stake in Onesource Specialty Pharma Limited to 30.19%Pronomz Ventures LLP Increases Stake in Onesource Specialty Pharma Limited to 30.19%
Pronomz Ventures LLP disclosed the acquisition of 33,906 additional equity shares in Onesource Specialty Pharma Limited through open market purchases on January 30, 2026. The transaction increased the promoter group's collective shareholding from 30.17% to 30.19% of the total share capital. The disclosure was made under SEBI's substantial acquisition regulations, with the company maintaining its equity capital at 11,46,21,201 shares listed on BSE and NSE.
*this image is generated using AI for illustrative purposes only.
Onesource Specialty Pharma Limited has received a regulatory disclosure from Pronomz Ventures LLP regarding the acquisition of additional equity shares. The disclosure, made under Regulation 29(2) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011, details a strategic increase in shareholding by the promoter group entity.
Transaction Details
Pronomz Ventures LLP acquired 33,906 equity shares of Onesource Specialty Pharma Limited through open market purchases on January 30, 2026. The acquisition represents 0.03% of the company's total share capital.
| Parameter | Details |
|---|---|
| Shares Acquired | 33,906 |
| Acquisition Method | Open Market |
| Transaction Date | January 30, 2026 |
| Share Type | Equity Shares |
| Percentage Acquired | 0.03% |
Shareholding Pattern Changes
The acquisition resulted in a marginal increase in the promoter group's collective shareholding. Before the transaction, Pronomz Ventures LLP and its persons acting in concert held 3,45,71,199 shares, representing 30.17% of the total voting capital.
| Holding Period | Number of Shares | Percentage |
|---|---|---|
| Before Acquisition | 3,45,71,199 | 30.17% |
| After Acquisition | 3,46,05,105 | 30.19% |
| Net Change | 33,906 | 0.03% |
Promoter Group Structure
The disclosure identifies Pronomz Ventures LLP as the acquirer, with several entities and individuals classified as persons acting in concert. The group includes:
- Karuna Business Solutions LLP
- Tenshi Pharmaceuticals Private Limited
- Arco Lab Private Limited
- Arun Kumar Pillai
- Vineetha Mohanakumar Pillai
- Padmakumar Karunakaran Pillai
- Sajitha Pillai
- Rajitha Gopalakrishnan
- Aditya Arun Kumar
- Hemalatha Pillai
Company Capital Structure
Onesource Specialty Pharma Limited maintains a stable equity share capital structure. The company's total equity share capital remains unchanged at 11,46,21,201 equity shares of Rs. 1 each, fully paid up. The shares are listed on both BSE Limited (Scrip Code: 544292) and National Stock Exchange of India Limited (Scrip Code: ONESOURCE).
Regulatory Compliance
The disclosure was signed by Jyothinarayasha Sriraman Ramaprasad, Designated Partner of Pronomz Ventures LLP (DIN: 00173696), on February 02, 2026. The filing ensures compliance with SEBI regulations governing substantial acquisitions and maintains transparency in shareholding changes for publicly listed companies.
Historical Stock Returns for Onesource Specialty Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +8.15% | +11.42% | -26.20% | -31.00% | -2.85% | -24.26% |
17
